|
Cognition
Therapeutics Inc.
Discovering
small
molecule
therapeutics for Alzheimer's and other neurodegenerative
diseases
Cognition
Therapeutics
welcomes
inquiries from potential investors
Please contact Hank
Safferstein at 412.770.1621
|
Careers
Cognition Therapeutics, Inc. is a drug discovery
company developing small molecule therapeutics that block the protein
oligomers responsible for Alzheimer’s disease. These oligomers
interfere with molecular memory mechanisms at the earliest stages of
neurodegenerative disease. Located in Pittsburgh’s historic
South Side, we are seeking highly motivated individuals to work in a
dynamic start-up company environment.
Research Scientist, Neurobiology
The candidate will be a key contributor in a scientific
research team developing cutting-edge cell-based assays.
Responsibilities include assay development using primary neuronal
cultures, compound library screen execution and statistical data
analysis, and studies of compound mechanism of action. The candidate
will work with others in a team-based environment and make formal
presentations of experimental results to the company.
Qualifications
- Ph.D. in neurobiology, industry experience a plus
- Background in learning and memory biology,
neurodegenerative disease biology
- Technical expertise in primary neuronal cultures,
immunohistochemistry, westerns, ELISAs, microscopy, automated imaging
with Cellomics VTI platform
Please send your resume and references to: info@cogrx.com
Cognition Therapeutics, Inc. is an equal opportunity
employer.
Copyright ©
2007—2011 Cognition Therapeutics, Inc. All rights reserved.
|